GLOBAL BONE MARROW TRANSPLANT MARKET FORECAST 2018-2026

GLOBAL BONE MARROW TRANSPLANT MARKET FORECAST 2018-2026

  • May 2018 •
  • 135 pages •
  • Report ID: 5391573 •
  • Format: PDF
KEY FINDINGS
Propelled by the growing prevalence of cancer and huge funding for regenerative medicines by the federal government, the global bone marrow transplant market is expected to rise with a CAGR of 5.45% over the forecast period of 2018-2026.

MARKET INSIGHTS
The global bone marrow transplant market is segmented on the basis of end-users, indications and transplant type.The end-users for this market are hospitals, multi-specialty clinics and ambulatory surgical centres.

The indications segment of the bone marrow transplant market includes acute leukaemia, multiple myelomas, Hodgkin lymphoma, Non-Hodgkin lymphoma, solid tumours and other indications. The market by transplant type is segmented into allogenic bone marrow transplant and autologous bone marrow transplant.

REGIONAL INSIGHTS
The regional segmentation of the global bone marrow transplant market is done into Europe, Asia-Pacific, North America and rest of the world.The Asia-Pacific bone marrow transplant market is anticipated to progress with the fastest CAGR over the forecast period.

Growing investments in public and private sectors to cater to the needs of the medical needs of the ever-growing population in China and India are contributing to the market growth in this region.However, a major chunk of the global market share is expected to be captured by the European bone marrow transplant market.

The region is witnessing increasing cases of breast, prostate and colorectal cancer. Also, the government in UK and Spain are encouraging proactive policies to increase the market demand in this region.

COMPETITIVE INSIGHTS
Some of the key companies engaged in the bone marrow transplant market are Affymetrix Inc. (Acquired By Thermofisher), Abbott Laboratories, Agendia N.V, Ambrilia Biopharma Inc, Agilent Technologies Inc, Astellas Pharma Inc, Diadexus Inc. (Acquired By Diazyme Laboratories), Qiagen N.V, Illumina Inc, Roche Diagnostics Ltd, Sanofi and Stryker Corporation.